Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open-Label Pilot Study of Arginine Replacement Therapy in Children Hospitalized With COVID-19

NCT05855330 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05855330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05855330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open-Label Pilot Study of Arginine Replacement Therapy in Children Hospitalized With COVID-19
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Recruiting
Start date
January 8, 2024
Completion date
June 30, 2028
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19